Longevity Pattern Clinical Operating System™
Metabolic dysfunction is not a calorie problem. It is a signaling problem at the cellular level.
Hallmark Mapping
Which aging mechanisms does this pattern activate?
Clinical Expression
How does this pattern show up in the patient?
Mechanistic Insight
The metabolic/mitochondrial pattern is rooted in a breakdown of cellular energy signaling. Mitochondria lose efficiency — ATP production declines, reactive oxygen species accumulate, and the cell’s ability to adapt to energy demands is compromised.
Nutrient sensing pathways — particularly AMPK and mTOR — become dysregulated. AMPK, the body’s master fuel gauge, loses sensitivity. mTOR signaling becomes chronically activated, suppressing autophagy and impairing cellular cleanup and recycling.
Insulin resistance develops as receptor signaling degrades, driving glucose into storage rather than utilization. The result is a compounding loop of metabolic inefficiency: poor fuel switching, visceral fat accumulation, inflammation, and progressive energy decline.
This is not a calorie issue. This is a cellular energy signaling problem.
Clinical Objective
Single Peptides
Each peptide targets a specific mechanism within this pattern.
A mitochondria-derived peptide that activates AMPK and improves metabolic flexibility. MOTS-c enhances insulin sensitivity, promotes fat oxidation, and supports cellular stress adaptation — making it a foundational tool in metabolic pattern management.
A GHRH analogue that selectively reduces visceral adiposity while supporting GH axis signaling. Tesamorelin improves body composition, metabolic markers, and energy production without suppressing endogenous GH output.
A selective GH secretagogue that promotes clean, pulsatile GH release. Ipamorelin supports anabolic repair, fat metabolism, and recovery without cortisol or prolactin side effects.
A GHRH analogue that extends GH pulse duration and supports sustained metabolic and regenerative signaling. Combined with Ipamorelin, it provides a synergistic GH axis optimization.
A fragment of the GH molecule that retains fat-metabolizing activity without anabolic or IGF-1-driven effects. AOD-9604 directly stimulates fat breakdown and inhibits lipogenesis.
A small molecule inhibitor of NNMT that supports NAD+ availability and metabolic efficiency. Enhances mitochondrial function and promotes fat oxidation in metabolically compromised patients.
GLP-1/GIP receptor agonists that function as powerful metabolic signaling therapies. While not traditional peptides, these agents profoundly improve insulin sensitivity, reduce visceral fat, and recalibrate appetite and metabolic homeostasis. Clinical note: these agents require appropriate prescribing oversight and patient selection.
Protocol Blends
Select a tier to explore the blends appropriate for each stage of clinical intervention.
Mechanistic Rationale
Why / When to Choose It
Mechanistic Rationale
Why / When to Choose It
Mechanistic Rationale
Why / When to Choose It
Mechanistic Rationale
Why / When to Choose It
Mechanistic Rationale
Why / When to Choose It
Mechanistic Rationale
Why / When to Choose It
Mechanistic Rationale
Why / When to Choose It
Mechanistic Rationale
Why / When to Choose It
The Longevity Pattern Clinical Operating System™ allows you to:
